Heinz Christoph, Cramer Nicolai
Ecole Polytechnique Fédérale de Lausanne EPFL SB ISIC LCSA BCH 4305 CH-1015 Lausanne, Switzerland.
Chimia (Aarau). 2016;70(4):258-62. doi: 10.2533/chimia.2016.258.
Fijiolide A is a secondary metabolite isolated from a marine-derived actinomycete of the genus Nocardiopsis. It was found to significantly reduce the TNF-α induced activity of the transcription factor NFκB, which is considered a promising target for the treatment of cancer and inflammation-related diseases. We disclose an enantioselective synthesis of fijiolide A enabled by a fully intermolecular, yet regioselective cyclotrimerization of three unsymmetrical alkynes to construct its tetra-substituted arene core. An atropselective macroetherification enables the assembly of the strained [2.6]paracyclophane motif. A late-stage glycosylation of the macrocyclic aglycone at its tertiary alcohol position allowed for the first total synthesis of fijiolide A.
斐济奥内酯A是从海洋来源的诺卡氏菌属放线菌中分离出的一种次生代谢产物。已发现它能显著降低肿瘤坏死因子-α诱导的转录因子NFκB的活性,而NFκB被认为是治疗癌症和炎症相关疾病的一个有前景的靶点。我们报道了一种对映选择性合成斐济奥内酯A的方法,该方法通过三种不对称炔烃的完全分子间但区域选择性的环三聚反应来构建其四取代芳烃核心。一种阻转选择性大环醚化反应实现了张力[2.6]对环芳烷结构单元的组装。大环苷元在其叔醇位置的后期糖基化反应实现了斐济奥内酯A的首次全合成。